The Obama administration and leading members of Congress are clashing over a new Medicare payment rule that could compromise patient care, impede development of a fledgling part of the biologics industry, and make it more difficult to track patient safety issues. At issue is government payment policy for a new class of drugs called “biosimilars”—drugs that are similar but not identical to the original brand name biologic drug.
In most states, consumers with HIV or AIDS who buy silver-level plans on the insurance marketplaces find limited coverage of common drug regimens they may need and high out-of-pocket costs, according to a new analysis.
Yesterday’s post discussed what we know about Obamacare as its third open enrollment season commences. Here are four major questions about the future of Obamacare that remain unanswered.
Obamacare’s third open enrollment season kicked off yesterday, beginning the next chapter in its turbulent history. Today’s post discusses what we know about Obamacare. Tomorrow’s will discuss what we don’t yet know.
Many health plans sold through the Affordable Care Act in 2015 are so limited they don’t offer patients access to some medical specialists such as endocrinologists, rheumatologists and psychiatrists, a new study suggests. That may be forcing some patients to pay thousands of dollars out of their own pockets for any care provided by these specialists.
The cataract of insurance co-op failures—nine down, 14 to go—has liberals defensive over ObamaCare. Most amusing is their attempt to blame this debacle conceived by liberals and perpetrated by liberals on, yes, Republicans.
Federal investigators from the Government Accountability Office said on Thursday that they had discovered many errors in eligibility decisions under the Affordable Care Act that had led the government to pay for duplicate coverage for some people and an excessive share of costs for others.
The investigators said some people were getting subsidies for private insurance at the same time they were enrolled in Medicaid.
Nearly 67,000 customers of Consumers’ Choice Health Insurance will have to shop for new insurance at the end of the year when the company shuts down its operations in 2016.
The state Department of Insurance made the announcement on Thursday. The company and the state agency did not give specifics on what precipitated the closure, only saying a look at long-term sustainability showed problems.
Wyoming’s second largest health insurance company is closing down.
The state Department of Insurance announced Wednesday that WINhealth will shut down Dec. 31 because of financial problems. The company has been in business since 1996.
State Insurance Commissioner Tom Glause says the state will help some 13,800 people covered by WINhealth plans to find new insurance.
Federal officials have a secret list of 11 Obamacare health insurance co-ops they fear are on the verge of failure, but they refuse to disclose them to the public or to Congress, a Daily Caller News Foundation investigation has learned.
Just in the last three weeks, five of the original 24 Obamacare co-ops announced plans to close, bringing the total of failures to nine barely two years after their launch with $2 billion in start-up capital from the taxpayers under the Affordable Care Act.